Ketazocine
Ketazocine is a benzomorphan opioid analgesic that was developed in the 1960s. It is known for its unique pharmacological profile, particularly its action as a kappa-opioid receptor agonist. Ketazocine has been primarily used in scientific research to study the effects of kappa-opioid receptor activation.
Pharmacology[edit | edit source]
Ketazocine acts as a potent agonist at the kappa-opioid receptor and has a high affinity for this receptor subtype. Unlike many other opioids, ketazocine has minimal activity at the mu-opioid receptor, which is typically associated with the euphoric and addictive properties of opioids. This selective action makes ketazocine a valuable tool in the study of kappa-opioid receptor functions and their role in pain modulation, mood regulation, and other physiological processes.
Effects[edit | edit source]
Activation of the kappa-opioid receptor by ketazocine can produce a range of effects, including analgesia, dysphoria, and hallucinations. The analgesic effects are particularly notable because they occur without the significant risk of addiction and respiratory depression that is commonly associated with mu-opioid receptor agonists. However, the dysphoric and hallucinogenic effects limit the clinical use of ketazocine as an analgesic.
Research Applications[edit | edit source]
Ketazocine has been used extensively in research to explore the role of kappa-opioid receptors in various physiological and pathological processes. Studies have investigated its potential in treating conditions such as pain, depression, and substance use disorder. The unique properties of ketazocine have also made it a subject of interest in the development of new therapeutic agents that target the kappa-opioid receptor.
Chemical Structure[edit | edit source]
Ketazocine belongs to the benzomorphan class of opioids, which are characterized by their distinct chemical structure. The benzomorphan core provides the framework for the molecule's interaction with opioid receptors.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
